
Image credit: Howard Berg
Overdose from opiates has skyrocketed. According to the National Center for Health Statistics, on average, 130 Americans die every day from an opioid overdose. The high cost of antidotes such as NARCAN® prevents many first responders from having access to lifesaving antidotes when they need it most.
Researchers at the Donald Danforth Plant Science Center have identified a new method of producing these compounds using a microorganism discovered in a waste stream associated with the processing of opium poppy. This green chemistry process has the potential to greatly reduce the cost of the antidote drugs as well as decrease chemicals currently used that result in large amounts of harmful waste. Details of the discovery were published as the cover story in the journal Nature Sustainability: “Enzyme morphinan N-demethylase for more sustainable opiate processing”.
“Enzymes perform reactions at efficiencies that surpass synthetic chemistry, thereby reducing the cost and impact of drug production on the environment. We work now to optimize production levels of the enzyme to a scale sufficient for industrial processes. Greener manufacturing would make a difference in people’s lives,” said Megan Augustin, lead author and research associate in the Kutchan lab at the Danforth Center.
Naturally occurring opiates, such as morphine and thebaine, are produced in poppy species. Thebaine is converted into painkillers and opiate addiction treatments, the latter requiring a chemical reaction called N-demethylation. Current opiate N-demethylation utilizes noxious reagents, resulting in harmful waste. One way to make opiate production more sustainable is to use enzymes rather than chemicals. Microorganisms provide a rich source of enzymes useful for metabolizing unique compounds in their environment. Augustin and her colleagues probed an opium processing waste stream sample to identify an organism capable of catalyzing opiate N-demethylation. To identify a biocatalyst, a sludge sample was subjected to minimal medium containing thebaine as the sole carbon source. This led to the discovery of Thebainfresser, a Methylobacterium that metabolizes opiates by removing the N-methyl group. N-demethylation was induced following growth in minimal medium, a characteristic that led to discovery of the underlying gene MND(morphinan N-demethylase). The enzyme MND was found to be robust and versatile, N-demethylating structurally diverse substrates at varying temperatures and pH levels. In addition, MND tolerated selected organic solvents and maintained activity when immobilized. These properties make it an attractive candidate for further development for pharmaceutical manufacture.
Learn more: NEW RESEARCH REVEALS SUSTAINABLE METHOD TO PRODUCE LIFESAVING OPIATE ANTIDOTES AT A REDUCED COST
The Latest on: Opioid antidotes
[google_news title=”” keyword=”opioid antidotes” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Opioid antidotes
- As billions roll in to fight the US opioid epidemic, one county shows how recovery can workon November 29, 2023 at 7:35 am
Instead, distributing the opioid antidote happens elsewhere. At the Family Resource Center, the quick response team compiles lists of overdose survivors and people with substance use disorder who ...
- Opioid crisis has reached Denmark – more young people are seeking helpon November 28, 2023 at 4:00 pm
“Opioids are the drug on the illegal market that kills the ... It only takes two minutes,” says Michael Lodberg, social entrepreneur and head of Antidote Danmark, an association that works to prevent ...
- B.C. in court against pharma companies in bid to certify opioid class-action lawsuiton November 27, 2023 at 7:04 pm
The British Columbia Supreme Court should certify a class-action lawsuit against opioid makers on behalf of all provinces and territories to save time and money on what would otherwise be 13 ...
- B.C. in court against pharma companies in bid to certify opioid class-action lawsuiton November 27, 2023 at 12:25 pm
Sharma says the action to obtain costs associated with the opioid crisis is a first of its kind in Canada, and one defendant, Purdue Pharma, has already settled with the province for $150 million.
- Neustatter: Save lives by getting trained on opioid antidote naloxoneon November 26, 2023 at 3:01 am
Wanting to help spread the word that the FDA has made the opioid antidote naloxone available over the counter as of March, I contacted a friend who is a paramedic ...
- Save lives, get trained on opioid antidoteon November 25, 2023 at 4:00 pm
"There are many myths and mistaken beliefs about antidotes to opioid overdose," he told us. For instance, stimulant drugs don't reverse the effects. It's only naloxone that does — by having a ...
- Opioid-overdose antidote naloxone in demand after state election officials receive fentanyl-laced envelopes in mailon November 20, 2023 at 3:01 pm
Even if there’s little risk from incidental contact with the synthetic opioid, having the antidote on hand isn’t a bad idea amid an addiction epidemic that is killing more than 100,000 people in the U ...
- Officials stock up on overdose antidote naloxone after fentanyl-laced letters disrupt vote countingon November 18, 2023 at 9:52 am
The suspicious letters sent to vote centers and government buildings in six states this month were undeniably scary, some containing traces of fentanyl or white powder, accompanied by ...
- Bill promotes antidote to opioid overdoseson November 17, 2023 at 2:29 pm
Naloxone is a life-saving drug that is used to quickly reverse an opioid overdose. It functions by attaching itself to the same brain receptors that opioids bind to. State Senator Jason Brodeur, a ...
- New pill-sized device that monitors breathing from INSIDE the body to detect opioid overdoses successfully clears human trialson November 17, 2023 at 7:37 am
A new pill-sized device that can safely monitor life-saving vital signs from inside the stomach has successfully cleared the first human trials successfully in the US.
via Bing News